Ren Z et al. |
Inhibition of type I and type II geranylgeranyl-protein transferases by the monoterpene perillyl alcohol in NIH3T3 cells. |
1997 |
Biochem. Pharmacol. |
pmid:9296357
|
Lewis KA and Hohl RJ |
Modulation of RAS expression in human malignant cells by dietary supplements. |
1997 |
Nutrition |
pmid:9357036
|
Zweibel J et al. |
Clinical trials referral resource. Clinical trials with perillyl alcohol. |
1997 |
Oncology (Williston Park, N.Y.) |
pmid:9436188
|
Stayrook KR et al. |
Induction of the apoptosis-promoting protein Bak by perillyl alcohol in pancreatic ductal adenocarcinoma relative to untransformed ductal epithelial cells. |
1997 |
Carcinogenesis |
pmid:9276644
|
Fulton GJ et al. |
Oral monoterpene therapy (perillyl alcohol) reduces vein graft intimal hyperplasia. |
1997 |
J. Surg. Res. |
pmid:9202658
|
Reddy BS et al. |
Chemoprevention of colon carcinogenesis by dietary perillyl alcohol. |
1997 |
Cancer Res. |
pmid:9012468
|
Bardon S et al. |
Monoterpenes inhibit cell growth, cell cycle progression, and cyclin D1 gene expression in human breast cancer cell lines. |
1998 |
Nutr Cancer |
pmid:9824849
|
Barthelman M et al. |
Inhibitory effects of perillyl alcohol on UVB-induced murine skin cancer and AP-1 transactivation. |
1998 |
Cancer Res. |
pmid:9485025
|
Ripple GH et al. |
Phase I clinical trial of perillyl alcohol administered daily. |
1998 |
Clin. Cancer Res. |
pmid:9607573
|
Tao L and Pereira MA |
Quantification of carvone, cineole, perillaldehyde, perillyl alcohol and sobrerol by isocratic high-performance liquid chromatography. |
1998 |
J Chromatogr A |
pmid:9468652
|